1. Home
  2. Ardian

Category: BIO

Lab testing service business GBA continues decade-long run of private equity ownership with Ardian investment

Private equity investment major Ardian has bought a majority stake in bio-analytical lab testing services business GBA Group.

BGF backs human cell disease model startup DefiniGEN

UK investment house BGF has backed a £3.25m funding round for DefiniGEN, a provider of human cell products and services.

Life sciences investor Catalio Capital strikes $100m hard for for second venture capital fundraise

Life sciences investor Catalio Capital Management has hit the $100m hard cap for its second venture capital fundraise.

Fledgling private equity house bd-capital picks probiotics pioneer Symprove for debut deal

Newly-launched private equity house bd-capital has sealed its first investment by backing Symprove, a startup attempting to disrupt the £35bn probiotics market.

Spain’s Ysios hits €155m for third life sciences fund, could raise up to €200m

Spanish early stage investment house Ysios Capital has hit €155m for its third life science fund - and could go as high as €200m for the vehicle.

4BIO Capital gets big pharma backing for Fund II raise, eyes $150m for final close

Advanced therapies-focused venture capital firm 4BIO Capital has picked up a strategic investment in its newest fund from specialist pharma and biotech business Kyowa Kirin.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.